Shanghai Serum Bio Technology Co (SHSE:688163) Net Income (Continuing Operations) : ¥37.2 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Shanghai Serum Bio Technology Co Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Shanghai Serum Bio Technology Co's Net Income (Continuing Operations) for the three months ended in Mar. 2024 was ¥1.5 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥37.2 Mil.

Shanghai Serum Bio Technology Co Net Income (Continuing Operations) Historical Data

The historical data trend for Shanghai Serum Bio Technology Co's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Serum Bio Technology Co Net Income (Continuing Operations) Chart

Shanghai Serum Bio Technology Co Annual Data

Trend

Dec13

Dec14

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income (Continuing Operations)

Get a 7-Day Free Trial

65.76

63.17

76.48

64.20

38.77

Shanghai Serum Bio Technology Co Quarterly Data
	Dec16	Dec17	Dec18	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Income (Continuing Operations)	Get a 7-Day Free Trial															3.02	23.89	23.89	-12.02	1.48

Shanghai Serum Bio Technology Co Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥37.2 Mil.

Shanghai Serum Bio Technology Co (SHSE:688163) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Shanghai Serum Bio Technology Co Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Shanghai Serum Bio Technology Co's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Serum Bio Technology Co (SHSE:688163) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Serum Bio Technology Co Ltd (SHSE:688163) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1288, Huaqing Road, Qingpu District, Shanghai, CHN, 201707

Website

http://www.serum-china.com.cn

Shanghai Serum Bio Technology Co Ltd is engaged in the research, development, production and sales of preventive and therapeutic drugs in the field of biotoxins and biosafety.

Shanghai Serum Bio Technology Co (SHSE:688163) Headlines

No Headlines